Abbott says market overestimating sales hit from new diabetes drugs
Go back to Abbott says market overestimating sales hit from new diabetes drugs| Abbott Laboratories (NYSE: ABT) | Delayed: 88.11 -0.3 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.41 | 52 Week High | $46.38 | |||
| Open | $88.15 | 52 Week Low | $36.00 | |||
| Day High | $88.59 | P/E | 58.74 | |||
| Day Low | $87.21 | EPS | $1.50 | |||
| Volume | 4,470,794 | |||||
